Investor Presentation
- Debt-free balance sheet (D/E of 0.0) allows expansion via 100% internal accruals.
- High core operating efficiency with ROCE at 24% (and Q1 FY27 annualized much higher).
- Strong Q1 FY27 performance with 53.3% revenue growth and 42.9% PAT growth.
- Capacity expansion of 33% (to 100k MTPA) is near completion (September 2026).
- Strategic shift to high-margin specialty grades via Nippon A&L collaboration.
- High raw material dependency on imported Styrene, Acrylonitrile, and Butadiene (70-80% of costs).
- Sensitivity to crude oil price volatility and forex fluctuations.
- Intense competition from low-cost imports of ABS resins.
- Slight EBITDA margin contraction (86 bps) in Q1 FY27 due to raw material cost pressures.
1. Ramp-Aware Impact Math
- Current Base: TTM Revenue of ₹1,276 Cr and TTM PAT of ₹180 Cr. Q1 FY27 annualized revenue stands at ~₹1,888 Cr based on the latest ₹472.2 Cr quarter.
- Capex & Capacity: The ₹200 Cr capex expands ABS capacity by 33.3% (from 75k MTPA to 100k MTPA). Commissioning is scheduled for September 2026.
- Year 1 (FY27) Impact: With commissioning in mid-FY27, we expect a partial volume contribution. Assuming a 50% utilization of the new capacity in its first 6 months, Year 1 revenue uplift is estimated at 15% over the FY26 base.
- Steady-State (FY28) Impact: Full utilization of the 100k MTPA capacity is expected to drive a 33% revenue uplift over the FY26 base, pushing annual revenue to ~₹1,700 Cr.
- Earnings Impact: Assuming a conservative PAT margin of 13.0% (accounting for raw material volatility vs. Q1 FY27's 13.6%), steady-state PAT is projected at ~₹221 Cr. This translates to an EPS of ₹8.90 (a 23% increase over TTM EPS of ₹7.24).
2. Industry Capital-Intensity & CAGR
- Capital Intensity: Medium. Debottlenecking existing plants requires lower capital and shorter timelines than greenfield setups.
- Industry CAGR: Domestic ABS demand is expected to grow at 12% CAGR, driven by automotive (EV lightweighting) and consumer electronics. Import substitution remains a massive structural tailwind as India is a net importer of ABS.
3. Multibagger Quality
- Earnings Acceleration: Q1 FY27 PAT grew 42.9% YoY, showing a sharp acceleration from the flat growth observed in FY25.
- Financial Health: Zero debt, high ROCE (24.0% TTM, with Q1 FY27 annualized ROCE exceeding 40%), and stable promoter holding of 57.5% make this a high-quality compounder candidate.
4. Valuation & Scenarios
- Base Case (50% Upside): Successful commissioning by Sep 2026, steady ramp-up to 85% utilization by FY28, margins hold at 13-14%, P/E re-rates slightly to 20x. Target price: ₹189.
- Bull Case (90% Upside): Rapid ramp-up, high demand for specialty grades (Nippon A&L) pushes margins to 15%+, P/E re-rates to 25x (peer premium). Target price: ₹240.
- Bear Case (-20% Downside): Crude oil spike squeezes margins to <10%, delay in capacity utilization, P/E contracts to 12x. Target price: ₹100.
5. Verdict Rationale
BEPL is a strong candidate due to its rare combination of high ROCE, zero debt, immediate capacity catalyst (Sep 2026), and strong earnings acceleration (Q1 FY27 PAT +42.9%). Although the catalyst was disclosed 2 days prior, the market has not fully priced in the steady-state earnings power of the expanded capacity.